Advanced Solutions BioAssemblyBot 400 Bioprinter
Product Details & Documents
Automated bioprinting solution for high-content screening with the BAB400 bioprinter for optimised 3D tissue and organoid workflow.
- Develop new drug targets
- Improved viability of 3D cell cultures
- Enhanced flexibility with integrated workflows
Consistently dispense, place, and print organoids for use in drug discovery with higher throughput vs. manual workflows. Test drug toxicity or efficacy on 3D models that are representative of native human tissues.
The reliability and reproducibility of BAB allows for consistency in maintaining improved viability of organoids over time.
BAB seamlessly integrates with high-content imagers for monitoring cell health or improved efficiency in end point assays.
Documents
TDS Automated Dispensing, Monitoring, and Assay Development of Hydrogel-Based Cellular Models TDS Automation of 3D Bioprinting Assays for High-Content Imaging and Assessment of Compound Effects TDS Bio-Printed 3D Liver Model and High-Content Imaging for Assessment of Compound Toxicity Effects TDS BioAssembly Bot 400_ More Than a Bioprinter TDS BioAssemblyBlot® 400 (BAB400) – More Than a Bioprinter
Fiche technique
Spécifications
- Désignation:BioAssemblyBot 400 series model bioprinter
Les recommandations seront personnalisées selon vos préférences d’achat uniquement si vous avez activé "Améliorer mon expérience d’achat" dans la page "Informations personnelles".
Sinon, vous recevrez des recommandations génériques.



